US equities
|
NVDA
$239.24
▲+0.14%
MU
$1,048.44
▼-1.46%
SPCX
$172.95
▲+1.09%
MRVL
$285.76
▲+5.35%
AMD
$651.25
▲+3.09%
INTC
$113.27
▼-2.51%
AVGO
$377.73
▲+4.20%
SNDK
$1,656.78
▼-2.78%
NVDA
$239.24
▲+0.14%
MU
$1,048.44
▼-1.46%
SPCX
$172.95
▲+1.09%
MRVL
$285.76
▲+5.35%
AMD
$651.25
▲+3.09%
INTC
$113.27
▼-2.51%
AVGO
$377.73
▲+4.20%
SNDK
$1,656.78
▼-2.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Psychoplastogens
Recent news which mentions Psychoplastogens
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
May 09, 2023
Tags
Next/Generation Psychedelics
Psychedelics
Markets
From
Benzinga
Delix: Elucidating How Psychedelics Actually Induce Neuroplasticity Vs. SSRIs
February 17, 2023
Tags
News
Benzinga
Psychoplastogens
From
Benzinga
Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
February 16, 2023
Tickers
PSYCF
Tags
Market News
Top Stories
Guidance
From
Benzinga